slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,58 CNY | +1,36% | +1,02% | +16,39% |
02/11 | Jumpcan Pharma registreert twee nieuwe geneesmiddelen | MT |
23/10 | Hubei Jumpcan Pharma's Q3-winst springt 4,8%, omzet daalt 6% | MT |
Omzet 2023 * | 10,04 mld. 1,39 mld. 1,29 mld. | Omzet 2024 * | 11,07 mld. 1,53 mld. 1,42 mld. | Marktkapitalisatie | 33,72 mld. 4,67 mld. 4,33 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | 2,49 mld. 344 mln. 319 mln. | Nettowinst (verlies) 2024 * | 2,77 mld. 383 mln. 355 mln. | EV/omzet 2023 * | 3,36 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 3,05 x |
K/w-verhouding 2023 * |
13,5
x | K/w-verhouding 2024 * |
12,2
x | Werknemers | 5.025 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 35,6% |
1 dag | +1,36% | ||
1 week | +1,02% | ||
Lopende maand | -1,14% | ||
1 maand | +1,53% | ||
3 maanden | +15,76% | ||
6 maanden | +36,85% | ||
Lopend jaar | +16,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 41 | 10-03-14 |
Hong Cun Yan
DFI | Director of Finance/CFO | 56 | 10-03-14 |
Long Xiang Cao
CHM | Chairman | 67 | 10-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Long Xiang Cao
CHM | Chairman | 67 | 10-03-14 |
Qu Rong Huang
BRD | Director/Board Member | 62 | 10-03-14 |
Fei Cao
CEO | Chief Executive Officer | 41 | 10-03-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.42% | 2 M€ | -16,04% | - | |
0.31% | 4 M€ | -2,96% | ||
0.19% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 36,58 | +1,36% | 7 025 488 |
26-03-24 | 36,09 | +0,92% | 3 992 601 |
25-03-24 | 35,76 | +0,73% | 7 464 102 |
22-03-24 | 35,5 | -0,36% | 3 113 700 |
21-03-24 | 35,63 | -1,60% | 4 522 398 |
slotkoers Shanghai S.E., 27 maart 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,39% | 4,67 mld. | |
+33,50% | 701 mld. | |
+26,24% | 571 mld. | |
+0,78% | 381 mld. | |
+20,85% | 334 mld. | |
+16,38% | 319 mld. | |
+2,79% | 210 mld. | |
+0,98% | 210 mld. | |
-6,58% | 201 mld. | |
-3,51% | 157 mld. |